Champions Oncology (CSBR) Operating Margin (QoQ) (2010 - 2026)
Champions Oncology (CSBR) Operating Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -211.00 |
| Jan 31, 2026 | -290.00 |
| Oct 31, 2025 | 500.00 |
| Jul 31, 2025 | 1,248.00 |
| Apr 30, 2025 | -4,265.00 |
| Jan 31, 2025 | 2,098.00 |
| Oct 31, 2024 | -403.00 |
| Jul 31, 2024 | 1,139.00 |
| Apr 30, 2024 | 1,951.00 |
| Jan 31, 2024 | -455.00 |
| Oct 31, 2023 | 342.00 |
| Jul 31, 2023 | -103.00 |
| Apr 30, 2023 | -4.00 |
| Jan 31, 2023 | -1,929.00 |
| Oct 31, 2022 | 212.00 |
| Jul 31, 2022 | 35.00 |
| Apr 30, 2022 | -871.00 |
| Jan 31, 2022 | 406.00 |
| Oct 31, 2021 | 379.00 |
| Jul 31, 2021 | 458.00 |